vida: extract claims from 2026-04-29-cms-mssp-py2024-2-4b-savings-vbc-structural-proof
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
- Source: inbox/queue/2026-04-29-cms-mssp-py2024-2-4b-savings-vbc-structural-proof.md - Domain: health - Claims: 0, Entities: 0 - Enrichments: 2 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
This commit is contained in:
parent
677c6de974
commit
46aff3366d
3 changed files with 14 additions and 66 deletions
|
|
@ -370,3 +370,10 @@ Current US system shows treatable mortality gap of 95 vs OECD average 77 per 100
|
|||
**Source:** CMS MSSP 2024 Performance Year Results, September 2025
|
||||
|
||||
MSSP ACOs in 2024 generated $2.48B in net savings while simultaneously outperforming non-ACO peers on depression screening (53.53% vs 44.42%), blood pressure control (71.21% vs 67.82%), and cancer screening. This empirically demonstrates the prevention-first flywheel in practice: aligned payment creates incentives that improve both cost and quality simultaneously, with per capita savings accelerating from $207 to $241 year-over-year.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** CMS MSSP 2024 Performance Year Results
|
||||
|
||||
MSSP ACOs demonstrate the aligned payment component is operational at scale: $2.48B net savings for eighth consecutive year, with quality metrics (depression screening 53.53% vs 44.42% non-ACO, BP control 71.21% vs 67.82%) improving alongside cost reduction. The flywheel is measurable.
|
||||
|
|
|
|||
|
|
@ -99,3 +99,10 @@ MSSP 2024 results show that within the program, 67% of ACOs now participate in d
|
|||
**Source:** HCPLAN 2024 Annual Survey, CMS 2026 final rule
|
||||
|
||||
HCPLAN 2024 survey (282.9M covered lives, 92.7% of US insured) shows full capitation doubled from 7% (2021) to 14% (2024), with total downside risk APMs reaching 28.5%. CMS 2026 final rule makes two-sided risk the 'organizing principle' for Medicare payment. MSSP reducing one-sided risk period from 7 to 5 years starting 2027. Trump administration actively pushing for MORE downside risk adoption to generate Medicare savings. The transition is accelerating: 4-year doubling rate with bipartisan federal policy support, though absolute penetration remains low.
|
||||
|
||||
|
||||
## Challenging Evidence
|
||||
|
||||
**Source:** CMS MSSP 2024 Performance Year Results
|
||||
|
||||
MSSP 2024 data shows two-thirds of ACOs in downside risk tracks generating $5.4B of $6.6B gross savings (82%), with CMS 2026 rules making two-sided risk the default. The 14% full risk statistic describes the aggregate payment landscape but masks rapid advancement in the largest federal VBC program.
|
||||
|
|
|
|||
|
|
@ -1,66 +0,0 @@
|
|||
---
|
||||
type: source
|
||||
title: "CMS Medicare Shared Savings Program: 2024 Performance Year Financial and Quality Results — Record $2.48B Net Savings"
|
||||
author: "Centers for Medicare & Medicaid Services"
|
||||
url: https://accountableforhealth.org/accountability-delivered-in-medicare-shared-savings-program-results-from-2024/
|
||||
date: 2025-09-09
|
||||
domain: health
|
||||
secondary_domains: []
|
||||
format: report
|
||||
status: unprocessed
|
||||
priority: high
|
||||
tags: [value-based-care, ACO, MSSP, CMS, payment-reform, structural-fix, belief-3]
|
||||
intake_tier: research-task
|
||||
---
|
||||
|
||||
## Content
|
||||
|
||||
CMS released performance year 2024 results for the Medicare Shared Savings Program (MSSP). Key findings:
|
||||
|
||||
**Financial performance:**
|
||||
- Net Medicare savings: $2.48 billion — record, 8th consecutive year of net savings
|
||||
- Gross savings (before shared savings payments): $6.6 billion total
|
||||
- 75% of ACOs earned shared savings, receiving $4.1 billion in performance payments
|
||||
- Per capita net savings: $241 (up $34 from 2023)
|
||||
- Per capita gross savings: $643 (up $128 from 2023)
|
||||
|
||||
**Risk track distribution:**
|
||||
- Two-thirds of ACOs participating in Level E or Enhanced (downside risk) tracks
|
||||
- ACOs in Level E and Enhanced generated more than two-thirds of all savings ($5.4B of $6.6B gross)
|
||||
|
||||
**Quality metrics:**
|
||||
- Nearly every ACO met CMS quality standards — continuing a decade-long trend
|
||||
- ACOs outperformed non-ACO physician groups on:
|
||||
- Screening for Depression and Follow-up Plan: 53.53% (ACO) vs 44.42% (non-ACO)
|
||||
- Controlling High Blood Pressure: 71.21% vs 67.82%
|
||||
- Improved performance on A1c control, cancer screening
|
||||
|
||||
**Enrollment context:**
|
||||
- Total MSSP ACO enrollment growing year-over-year
|
||||
- CMS 2026 rule making two-sided risk the default: new Ambulatory Specialty Model (ASM) for heart failure and low back pain, restricting one-sided MSSP participation
|
||||
|
||||
## Agent Notes
|
||||
|
||||
**Why this matters:** This is the empirical proof that value-based care's structural fix thesis (Belief 3) actually works at scale. $2.48B in net annual savings is not aspirational — it's measured, audited, and eighth-year consecutive. This is the strongest single piece of evidence in the KB that VBC is more than policy proposal.
|
||||
|
||||
**What surprised me:** The quality improvement alongside cost reduction. The classic critique of VBC is that it will cut costs by under-treating patients. The ACO data shows the opposite — ACOs outperform peers on depression screening, BP control, cancer screening WHILE generating $2.48B in savings. Cost and quality are moving together.
|
||||
|
||||
**What I expected but didn't find:** Any evidence of MSSP performance deteriorating. Given the MA disruptions (CMS tightening, UHG losses, Humana exits), I expected MSSP to show similar stress. Instead it's accelerating.
|
||||
|
||||
**KB connections:**
|
||||
- Directly confirms [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] — this is the state of the TRANSITION, not proof VBC doesn't work
|
||||
- Directly supports Belief 3: "Value-based care is the structural fix, but transition is slow"
|
||||
- Connects to [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
|
||||
|
||||
**Extraction hints:**
|
||||
- PRIMARY: "MSSP ACOs generated record $2.48B in net Medicare savings in 2024 for the eighth consecutive year, while maintaining superior quality performance compared to non-ACO peers — empirically confirming that cost and quality improvement are achievable simultaneously under value-based payment"
|
||||
- SECONDARY: Two-thirds of MSSP ACOs now in downside risk tracks — the transition IS advancing despite slow aggregate payment statistics
|
||||
- The per capita savings growth ($34 more in net, $128 more in gross vs. 2023) shows acceleration, not stagnation
|
||||
|
||||
**Context:** Released September 2025. Most recent publicly available MSSP performance data. CMS simultaneously issued 2026 rules expanding mandatory risk-bearing — the structural direction is accelerating.
|
||||
|
||||
## Curator Notes
|
||||
|
||||
PRIMARY CONNECTION: [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]
|
||||
WHY ARCHIVED: Belief 3 disconfirmation target — does VBC structural fix actually work? This is the strongest empirical answer: record $2.48B savings, 8th consecutive year, quality improving alongside costs. Disconfirmation FAILS — Belief 3 confirmed.
|
||||
EXTRACTION HINT: Focus on the cost-quality co-improvement (defeats the under-treatment critique) and the acceleration of downside risk adoption (2/3 of ACOs now in downside risk). Two claims, not one.
|
||||
Loading…
Reference in a new issue